Marion Moos

2.4k total citations · 1 hit paper
46 papers, 1.9k citations indexed

About

Marion Moos is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Marion Moos has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 24 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Marion Moos's work include Multiple Myeloma Research and Treatments (23 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Immunotherapy and Immune Responses (7 papers). Marion Moos is often cited by papers focused on Multiple Myeloma Research and Treatments (23 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Immunotherapy and Immune Responses (7 papers). Marion Moos collaborates with scholars based in Germany, France and United States. Marion Moos's co-authors include Melitta Schachner, Roland Tacke, Klaus Früh, David B. Teplow, Hartmut Goldschmidt, Dirk Hose, Friedrich W. Cremer, Bernard Klein, Anna Jauch and Anthony D. Ho and has published in prestigious journals such as Nature, Nucleic Acids Research and Blood.

In The Last Decade

Marion Moos

44 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin

1988 589 citations Marion Moos, Melitta Schachner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marion Moos Germany	20	1.0k	590	446	378	317	46	1.9k
M Moos Germany	18	742 0.7×	467 0.8×	384 0.9×	285 0.8×	164 0.5×	32	1.5k
Kyungmin Hahm United States	20	1.6k 1.5×	193 0.3×	293 0.7×	719 1.9×	191 0.6×	24	3.0k
Franck Gesbert France	20	1.1k 1.1×	585 1.0×	498 1.1×	472 1.2×	107 0.3×	35	2.0k
Zonghan Dai United States	20	1.0k 1.0×	650 1.1×	240 0.5×	100 0.3×	192 0.6×	29	1.8k
Andrew Goodearl United States	16	725 0.7×	218 0.4×	313 0.7×	338 0.9×	276 0.9×	26	1.6k
Leonid Eshkind Germany	18	1.6k 1.5×	846 1.4×	353 0.8×	665 1.8×	149 0.5×	31	2.9k
Chungyee Leung-Hagesteijn Canada	13	1.8k 1.7×	309 0.5×	418 0.9×	373 1.0×	280 0.9×	19	2.9k
Fred Sablitzky United Kingdom	30	2.0k 1.9×	235 0.4×	385 0.9×	1.2k 3.1×	96 0.3×	48	3.4k
Tamara Byk Israel	13	934 0.9×	928 1.6×	946 2.1×	877 2.3×	385 1.2×	15	2.6k
Dongping He United States	12	1.4k 1.4×	205 0.3×	620 1.4×	228 0.6×	330 1.0×	30	2.6k

Countries citing papers authored by Marion Moos

Since Specialization

Citations

This map shows the geographic impact of Marion Moos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Moos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Moos more than expected).

Fields of papers citing papers by Marion Moos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Moos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Moos. The network helps show where Marion Moos may publish in the future.

Co-authorship network of co-authors of Marion Moos

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Moos. A scholar is included among the top collaborators of Marion Moos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Moos. Marion Moos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weinhold, Niels, Jérôme Moreaux, Marc S. Raab, et al.. (2010). NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm. Genes Chromosomes and Cancer. 49(4). 333–341. 6 indexed citations

Christensen, Olaf, Stefanie Schmidt, Maud Condomines, et al.. (2009). Melan-A/MART1 Analog Peptide Triggers Anti-myeloma T-cells Through Crossreactivity With HM1.24. Journal of Immunotherapy. 32(6). 613–621. 26 indexed citations

Belle, Sebastian, Fang Han, Maud Condomines, et al.. (2008). Identification of HLA‐A2 restricted T‐cell epitopes within the conserved region of the immunoglobulin G heavy‐chain in patients with multiple myeloma. European Journal Of Haematology. 81(1). 26–35. 5 indexed citations

Lotz, Carina, Edite Antunes Ferreira, Marion Moos, et al.. (2005). Targeting Positive Regulatory Domain I-Binding Factor 1 and X Box-Binding Protein 1 Transcription Factors by Multiple Myeloma-Reactive CTL. The Journal of Immunology. 175(2). 1301–1309. 12 indexed citations

Cremer, Friedrich W., Jelena Bila, Mutlu Kartal‐Kaess, et al.. (2005). Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics. Genes Chromosomes and Cancer. 44(2). 194–203. 74 indexed citations

Cremer, Friedrich W., Mutlu Kartal‐Kaess, Dirk Hose, et al.. (2005). High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH. Cancer Genetics and Cytogenetics. 161(2). 116–124. 19 indexed citations

Mahtouk, Karène, Dirk Hose, Thierry Rème, et al.. (2005). Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene. 24(21). 3512–3524. 80 indexed citations

Bâkkus, Marleen, Diana Samson, Jane F. Apperley, et al.. (2004). Post‐transplantation tumour load in bone marrow, as assessed by quantitative ASO‐PCR, is a prognostic parameter in multiple myeloma. British Journal of Haematology. 126(5). 665–674. 52 indexed citations

Luft, Thomas, Marion Moos, Hartmut Goldschmidt, Anthony D. Ho, & Martin Görner. (2003). Dissociation of putative graft‐versus‐haematopoiesis and graft‐versus‐myeloma effects in patients with rapidly progressive multiple myeloma*. British Journal of Haematology. 123(4). 646–653. 16 indexed citations

10.

Voso, Maria Teresa, Simona Martin, Marion Moos, et al.. (2000). In vivo depletion of B cells using a combination of high‐dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non‐Hodgkin's lymphoma. British Journal of Haematology. 109(4). 729–735. 71 indexed citations

11.

Rottenburger, Christof, K Kiel, Friedrich W. Cremer, et al.. (1999). Clonotypic CD20⁺ and CD19⁺ B cells in peripheral blood of patients with multiple myeloma post high‐dose therapy and peripheral blood stem cell transplantation. British Journal of Haematology. 106(2). 545–552. 24 indexed citations

12.

Voso, Maria Teresa, Stefan Hohaus, Marion Moos, et al.. (1999). Autografting with CD34⁺ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content. British Journal of Haematology. 104(2). 382–391. 38 indexed citations

13.

Nolte, Christiané, Marion Moos, & Melitta Schachner. (1999). Immunolocalization of the neural cell adhesion molecule L1 in epithelia of rodents. Cell and Tissue Research. 298(2). 261–273. 48 indexed citations

14.

Bellos, Frauke, et al.. (1998). Leukapheresis cells of patients with multiple myeloma collected after mobilization with chemotherapy and G‐CSF do not bear Kaposi's sarcoma associated herpesvirus DNA. British Journal of Haematology. 103(4). 1192–1197. 2 indexed citations

15.

Hillenbrand, Rainer, Volker Steuber, Udo Bartsch, et al.. (1996). Structural Features of a Close Homologue of L1 (CHL1)in the Mouse: A New Member of the L1 Family of Neural Recognition Molecules. European Journal of Neuroscience. 8(8). 1613–1629. 103 indexed citations

16.

Bentz, Martin, et al.. (1996). High incidence of a second BCR-ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears. Cancer Genetics and Cytogenetics. 87(2). 107–111. 8 indexed citations

17.

Murea, S, et al.. (1996). Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses. Journal of Clinical Apheresis. 11(4). 185–194. 34 indexed citations

18.

Moos, Marion, et al.. (1995). Detection of minimal residual disease by polymerase chain reaction in b cell malignancies. Stem Cells. 13(S3). 42–51. 15 indexed citations

19.

Goldschmidt, Hartmut, et al.. (1995). Sequential high&hyphen;dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma. Stem Cells. 13(S3). 36–41. 4 indexed citations

20.

Moos, Marion, et al.. (1987). Transformation of soybean protoplasts from permanent suspension cultures by cocultivation with cells of Agrobacterium tumefaciens. Plant Molecular Biology. 9(2). 135–145. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact